-
Mashup Score: 7Smoking: cessation success in people with bipolar, schizophrenia and other psychoses | Indicators | NICE - 7 month(s) ago
This indicator covers the percentage of patients with schizophrenia, bipolar affective disorder and other psychoses recorded as current smokers in the previous 13 to 48 months, who were recorded as ex-smokers in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
Source: www.nice.org.ukCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Cardiovascular disease prevention: risk assessment (modifiable risk factors) | Indicators | NICE - 7 month(s) ago
This indicator covers the percentage of people aged 43 to 84 years with a modifiable risk factor who have a recorded cardiovascular disease (CVD) risk assessment score in the preceding 3 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
Source: www.nice.org.ukCategories: General Medicine News, CardiologistsTweet-
Here’s the new @NICEComms #cardiovascular disease prevention risk assessment (modifiable risk factors) indicator https://t.co/WpwT5J1ySI
-
-
Mashup Score: 9Cardiovascular disease prevention: risk assessment (general population) | Indicators | NICE - 7 month(s) ago
This indicator covers the percentage of people aged 45 to 84 years who have a recorded cardiovascular disease (CVD) risk assessment score in the preceding 5 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
Source: www.nice.org.ukCategories: General Medicine News, CardiologistsTweet-
Here’s a new @NICEComms #cardiovascular disease prevention risk assessment (general population) indicator. https://t.co/pDcv1buIWF
-
-
Mashup Score: 18Project documents | Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015] | Guidance | NICE - 7 month(s) ago
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015]
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet-
Reino Unido acuerda la financiación de exa-cel (terapia de edición génica) en #talasemia dependiente de transfusiones. Un panel de expertos en #hemoglobinopatías decidirá la indicación caso por caso. Aquí se puede consultar la documentación: https://t.co/MJHI4zwjVC https://t.co/KneUZlFo9n
-
-
Mashup Score: 6Project documents | Exagamglogene autotemcel for treating sickle cell disease [ID4016] | Guidance | NICE - 8 month(s) ago
Exagamglogene autotemcel for treating sickle cell disease [ID4016]
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet-
Ojalá la evaluación de la financiación de medicamentos fuese tan transparente en España como en Reino Unido,y ojalá sea tan exhaustiva. Hasta se aprende de matemáticas. Aquí,la evaluación de exa-cel (#TerapiaGénica en Hbpatías),a falta del último capítulo: https://t.co/KRe1b80ZSL
-
-
Mashup Score: 2Project documents | Tirzepatide for managing overweight and obesity [ID6179] | Guidance | NICE - 9 month(s) ago
Tirzepatide for managing overweight and obesity [ID6179]
Source: www.nice.org.ukCategories: General Medicine News, General HCPsTweet-
RT @shaungreen969: https://t.co/5FvDeenVgU @RoyLilley No 2 year limit NHS costs could be billions per year given the obesity crisis #Nice
-
-
Mashup Score: 10
This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet-
RT @AJMI_online: Pérdida de electrolitos de acuerdo al sitio corporal y a la patología: https://t.co/sYfbkJHq23 https://t.co/6F7ihK1bFh
-
-
Mashup Score: 3Overview | Dupilumab for treating moderate to severe atopic dermatitis | Guidance | NICE - 11 month(s) ago
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet-
What did I say abt wasting scarce @NHSEngland resources +++ on worthless drugs @sib313 @PharmRJ ? @NICEComms has a TAG on Dupilimumab https://t.co/rw3j441t7T https://t.co/gHqpVfzqfP
-
-
Mashup Score: 5
This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet-
RT @AJMI_online: Pérdida de electrolitos de acuerdo al sitio corporal y a la patología: https://t.co/sYfbkJHq23 https://t.co/6F7ihK1bFh
-
-
Mashup Score: 13Overview | Ovarian cancer: identifying and managing familial and genetic risk | Guidance | NICE - 12 month(s) ago
This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults
Source: www.nice.org.ukCategories: General Medicine News, Oncologists2Tweet-
https://t.co/jDGZZj21uX Delighted to see the new NICE Guideline NG241 out on - Ovarian cancer: identifying and managing familial and genetic risk. Huge effort over 2.5 years. Big Thank You to the entire Committee and the NICE team as well as stakeholders contributing to this
-
Here’s the new @NICEComms #smoking cessation success in people with bipolar, schizophrenia & other psychoses indicator https://t.co/5TZ4iibN3v